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What are our priorities?
The National Institute for Occupational Safety and Health (NIOSH) Immune, Infectious and Dermal Disease 
Prevention Program works with partners in industry, labor, trade associations, professional organizations, 
and academia. The program focuses on these areas:
• Reducing immune abnormalities (including immune aspects of asthma) associated with workplace 
exposures. 
• Reducing occupational skin disorders and exposures that result in disease.
• Reducing transmission of infectious diseases in the workplace.
What do we do?
• Conduct research to better understand the 
impact and basic mechanisms of occupational 
exposures to chemical, biological, or infectious 
agents on the immune system.
• Identify occupational allergens that cause 
disease in workers in high burden industries.
• Research occupational chemical exposures to 
develop strategies to prevent exposure and 
raise awareness of skin injury materials. 
• Maximize resources by using statistical 
modeling to prioritize chemicals to research, 
rather than investigating all potentially 
hazardous chemicals.
• Publish Skin Notation (SK) Profiles, hazard 
warnings used worldwide, to alert workers and 
employers to the health risks of skin exposures 
to workplace chemicals.
• Improve surveillance for hazard identification, 
exposure assessment, and risk characterization 
of chemicals absorbed through the skin that 
lead to immune or systemic toxicity (e.g., 
damage to internal organs).
• Increase awareness of occupational immune 
and dermal health issues through collaborations 
with NIOSH sector programs; contributions 
to field investigations; and publications and 
presentations of research findings. 
• Investigate the routes of transmission of 
influenza to help assess risk of infection in 
healthcare workers exposed to influenza 
patients and determine how the virus utilizes 
the infected patient’s own cellular machinery to 
mount an infection.
What have we accomplished?
• Completed a Health Hazard Evaluation 
investigating the microbial hazards at a 
medicinal cannabis manufacturing facility. 
• Published numerous research articles on the 
impact of antimicrobials on allergic disease and 
novel mediators of allergic disease.
• Published research which identified surgical 
masks and N95 respirators as potential personal 
bioaerosol samplers for the assessement of 
influenza exposure.
• Conducted investigations on the pulmonary 
immunology induced by repeated exposure to 
Stachybotrys chartarum.
What’s next?
• Conduct studies on how exposure to high-level 
disinfectants influence anti-viral immunity and 
susceptibility to influenza infection.
• Identify hazardous dermal exposures that occur 
in oil and gas workers.
• Investigate the immunotoxicity of perfluoroalkyl 
substances (PFAS), including those found in 
firefighting foams.  
• Characterize murine pulmonary immune 
responses to repeated inhalation exposure 
to the indoor fungal contaminant, Aspergillus 
versicolor. 
• Utilize animal models to further investigate the 
pathogenesis of isocyanate-induced asthma.
• Publish research on intervention strategies 
for the multi-drug resistant pathogen Candida 
auris,  which is an emerging public threat in the 
Health Care Sector.
• Investigate the relationship between increases 
in contact dermatitis cases and biocide 
raw material exposures used during paint 
manufacturing.
At-A-Glance
The Immune, Infectious and Dermal 
Disease Prevention Program primarily 
focuses on hazard identification to prevent 
and minimize the effects of work-related 
dermal and immune diseases. This 
snapshot shows recent accomplishments 
and upcoming work.
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Publication Spotlight:
Landscape Plant Selection Criteria for the 
Allergic Patient
To learn more, visit  
https://www.cdc.gov/niosh/programs/
idid/default.htmlMention of any company or product does not constitute 
endorsement by the National Institute for Occupational Safety and 
Health, Centers for Disease Control and Prevention.
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